Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS6880554 B1
Publication typeGrant
Application numberUS 09/642,982
Publication date19 Apr 2005
Filing date21 Aug 2000
Priority date22 Dec 1992
Fee statusLapsed
Also published asUS20050235986
Publication number09642982, 642982, US 6880554 B1, US 6880554B1, US-B1-6880554, US6880554 B1, US6880554B1
InventorsRonald Alan Coffee
Original AssigneeBattelle Memorial Institute
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Dispensing device
US 6880554 B1
Abstract
An inhaler, comprising an electrohydrodynamic comminution means, a means for partially or fully discharging the liquid comminution and a conduit through which the liquid comminution is administered, wherein the discharging means is arranged to be activated by inhalation of the user.
Images(5)
Previous page
Next page
Claims(8)
1. An inhaler for enabling inhaled administration to and via the nasal mucosa, the inhaler comprising a housing having an outlet duct providing an air passageway through which a user can inhale, the housing containing:
a liquid container having a liquid outlet; and
means for applying a high voltage to cause liquid issuing from the liquid outlet to emerge as a jet which breaks up into charged droplets which are caused, by the act of the user inhaling, to flow towards the outlet duct.
2. An inhaler for enabling inhaled administration to and via the nasal mucosa, the inhaler comprising a housing having an outlet providing an air passageway through which a user can inhale, the housing containing:
a liquid container having a liquid outlet; and
an applicator of a high voltage to cause liquid issuing from the liquid outlet to emerge as a jet which breaks up into charged droplets which are caused, by the act of the user inhaling, to flow towards the outlet duct.
3. An inhaler for enabling inhaled administration, the inhaler comprising a housing having an outlet duct defining a passageway through which air can be drawn by inhalation on the part of a user, the housing containing:
a capillary nozzle;
a container for containing a quantity of liquid to be supplied to the capillary nozzle; and
a voltage producer for producing a voltage in the liquid prior to issue from the container via the capillary nozzle to expose the liquid to an electric field to cause comminution of the liquid emerging from the capillary nozzle to produce a spray of electrically charged droplets, where, when a user inhales via the outlet duct, electrically charged droplets are supplied via the outlet duct for deposition in the user's airways.
4. An inhaler for enabling inhaled administration of a medicament to and via the nasal mucosa, the inhaler having a housing having an outlet duct defining a passageway through which air can be drawn by inhalation by a user, the housing containing:
a liquid container containing a quantity of liquid and having an outlet; and
a voltage applier for applying a voltage to the liquid before it emerges from the outlet to subject the liquid to an electric field to cause comminution of liquid emerging from the outlet to produce a spray of electrically charged droplets, wherein, when a user inhales via the outlet duct, electrically charged droplets are supplied via the outlet duct and into the user's airways.
5. An inhaler for enabling inhaled administration of a medicament to and via the lower respiratory tract, the inhaler having a housing having an outlet duct defining a passageway through which air can be drawn by inhalation by a user, the housing containing:
a liquid container containing a quantity of liquid and having an outlet; and
a voltage applier for applying a voltage to the liquid before it emerges from the outlet to subject the liquid to an electric field to cause comminution of liquid emerging from the outlet to produce a spray of electrically charged droplets, wherein, when a user inhales via the outlet duct, electrically charged droplets are supplied via the outlet duct and into the user's airways.
6. An inhaler for enabling inhaled administration to and via the nasal mucosa, the inhaler comprising a housing having an outlet duct providing an air passageway through which a user can inhale, the housing containing:
a liquid supplied for containing a quantity of liquid, the liquid supplier having a non-conductive sleeve with an outlet and also having a needle located within the sleeve; and
an electric field generator for generating an electric field at the sleeve outlet to cause liquid issuing from the sleeve outlet to emerge as a jet which breaks up into charged droplets for supply, in response to the user inhaling, to and via the nasal mucosa, the electric field generator including a voltage applier for applying a voltage to the liquid prior to issue from the outlet.
7. An inhaler for enabling inhaled administration to and via the nasal mucosa, the inhaler comprising a housing having an outlet duct providing an air passageway through which a user can inhale, the housing containing:
a liquid supplier for containing a quantity of liquid, the liquid supplier having an outlet; and
an induction charged adapted to induce a voltage at the liquid supplier outlet to cause liquid issuing from the outlet to emerge as a jet which breaks up into charged droplets for supply to a zone of deposition within the user's airways when air is drawn through the passageway by inhalation by the user.
8. An inhaler for enabling inhaled administration to and via the nasal mucosa, the inhaler comprising a housing having an outlet duct providing an air passageway through which a user can inhale, the housing containing:
a liquid supplier for containing a quantity of liquid, the liquid supplier having an outlet; and
a syringe pump for causing liquid to be pumped to the liquid supplier outlet; and
a voltage applier for applying a voltage to the liquid prior to issue from the liquid supplier outlet so as to subject the liquid to an electric field to cause comminution of liquid emerging from the outlet to produce a spray of electrically charged droplets to be supplied to a zone of deposition within the user's airways when air is drawn through the passageway by inhalation by the user.
Description

This is a Continuation of U.S. Ser. No. 08/492,204 filed Jun. 2, 1995, now Pat. No. 6,105,571 which is in turn a continuation of Ser. No. PCT/GB93/02634 filed Dec. 22, 1993.

The invention relates to a dispensing device for comminuting a liquid and the uses of such a device, especially in medicine.

Dispensing devices are known which produce a finely divided spray of liquid droplets by electrostatic (more properly referred to as ‘eletrohydrodynamic’) means. The droplet spray in such devices is generated by the application of an electric field to a liquid at a spray head or spray edge. The potential of the applied electric field is sufficiently high to provide comminution of the liquid from the spray head. The droplets produced are electrically charged and thus are prevented from coagulating by mutual repulsion.

Electrohydrodynamic sprayers have potential uses in many areas, including agriculture and the automotive industry and also for dispensing cosmetics and medicines.

United Kingdom patent number 1569707 describes such an electrohydrodynamic spray device principally for use in crop spraying.

United Kingdom patent number 2018627B discloses an electrohydrodynamic spray device wherein the charged droplet spray is fully or partially electrically discharged by means of an earthed electrode having a sharp or pointed edge and located downstream of the spray head. European Patent number 0234842 also uses this technology and relates to an inhaler in which charged droplet spray is discharged prior to inhalation by means of a sharp or pointed discharge electrode carrying an opposite charge to the droplet spray and located downstream of the spray head. The droplets are discharged to facilitate droplet deposition into the respiratory tract by preventing deposition of charged droplets onto the mouth and throat of the user.

A common feature of all known electrohydrodynamic spray devices is that the electric charge used to generate the spray is applied directly to the spray head. It has now surprisingly been found that the direct application of the field is not essential and that the electrohydrodynamic comminution of a liquid may be accomplished by inducing the required electric charge at the spray head. In addition and advantageously, it has been found that the comminutions produced can be partially or fully discharged prior to use.

This method of induced charging has been found to provide better comminution of liquids having lower electrical resistivity.

Accordingly, it is one aspect of the invention that there is provided an electrohydrodynamic dispensing device for comminuting a liquid, wherein the liquid is comminuted by an induced electrical charge.

The dispensing device normally comprises a comminution site, a means for supplying liquid to the comminution site and a means for inducing an electrical charge at the comminution size sufficient to comminute the liquid.

The comminution site may be any conventional electrohydrodynamic comminution site such as a surface or edge generally provided by a thin capillary tube, a nozzle or a slot defined by two parallel plates.

Appropriate means for supplying liquid to the comminution site include mechanical or electrically powered pumps which are capable of providing the required flow rate of liquid to the comminution site such as a syringe pump or the electrically powered pump described in EP 0029301.

The comminution means of the invention can be used with a large range of flow rates, but generally operates with flow rates in the range of between 0.1 to 500 μl L per second, such as 0.5 to 5 μL per second, especially for inhaled administration, or 10 to 200 μL per second, especially for agricultural use.

The means for inducing the electrical charge at the comminution site may be any conventional source of electrical charge which in use is capable of inducing a charge sufficient to comminute the liquid from the comminution means including a high voltage generator or a piezo-electric generator. The charge required is usually of the order of 1-20 kilovolts for example 10 kilovolts.

After formation of the liquid comminution, the electrically charged liquid droplets are attracted towards and will impact the means for inducing the electrical charge at the comminution site. In a preferred aspect of the present device, there is therefore provided a means for partially or fully electrically neutralising the liquid comminution before it impacts the induced charging means. One suitable means for partially or fully electrically discharging the liquid comminution is a sharp or pointed discharge electrode located downstream of the comminuted liquid.

The sharp or pointed discharge electrode may be earthed or it may be maintained at a polarity opposite to that of the induced charging means by connection to a suitable charging means. In either case the comminuted liquid is partially or fully discharged by a cloud of charged ions produced from the surrounding air having an opposite electrical charge to that on the comminuted liquid spray. The ion cloud is attracted towards, collides with and thereby partially or fully discharges the liquid spray.

In one particularly advantageous form of the device, the means for fully or partially discharging the liquid comminution is provided by a combination of the sharp or pointed discharge electrode and at least one capacitor, the capacitor acting to absorb the charge from the gaseous ions from the sharp or pointed discharge electrode until the induced comminution of the liquid is established, the capacitor is arranged to absorb the ions until it reaches a predetermined potential at which potential it ceases to absorb the ions thereby allowing them to partially or fully discharge the liquid comminution.

Generally, the capacitor is chosen to have a time constant having the same order as the time required to establish the liquid comminution spray cloud. Thus the time constant will have a value, in seconds, which is the product of the capacitance, C and the resistance, R, of the capacitor.

The value of CxR for the capacitor is chosen so that the capacitor will charge until it reaches a prearranged potential sufficient to modify the electric field, the capacitor then discharges towards the established spray cloud. Generally, the time-constant required will be of the order of seconds or a number of milliseconds. For example, a capacitor of 0.1 microfarad with a resistance of 10 megohms will produce a time constant of one second.

In yet a further aspect, the means for fully or partially discharging the liquid comminution is provided by an electrode arranged to have a first surface capable of producing an electric field sufficient to induce the required charge for liquid comminution in the comminution means and also to impart sufficient inertia to the liquid comminution so that it substantially bypasses the first surface, the electrode also having a second surface capable of producing an ionic discharge to fully or partially discharge the liquid comminution.

Generally, the second surface is shaped to have a sharp edge or a point which in use produces the ionic discharge.

Suitably, the electrode is an annular electrode coaxially located with respect to the intended flight path of the liquid comminution, in use, the upper surface of the annular electrode induces the required charge in the comminution means, the lower surface being shaped so as to produce the ionic discharge.

In operation the field pattern of the upper surface of the annular electrode is such that the comminution is directed onto an axial flight path with respect to the annular electrode and is provided with sufficient inertial force to substantially bypass the first surface, the comminution is then fully or partially discharged by the gaseous ions produced by the second surface.

The device of the invention may be used to dispense liquids comprising components useful for human or animal health care, such as medicaments for pharmaceutical or public health care use or medically useful compounds such as anesthetics.

Suitable liquids include liquids comprising components for agricultural use such as pesticides or biocides.

Suitable liquids include liquid cosmetic formulations.

Other suitable liquids include paints and inks. Also included are liquids for providing aromas.

Preferred liquids are pharmaceutically active liquids.

The communition means of the dispenser provides liquid droplets within the range of from about 0.1 to about 500 microns in diameter. More usually from 0.1 to 200 microns, such as 1.0 to 200 microns: Examples include droplets within the range of 5.0 to 100, 0.1 to 25, 0.5 to 10 or 10 to 20 microns. A favoured range for inhaled administration is 0.1 to 25 or 0.5 to 10 microns, especially for administration to the lower respiratory tract, and 10 to 25 microns, especially for administration to the upper respiratory tract.

For a given liquid the diameter of the droplets can be controlled by varying the applied voltage and liquid flow rate using routine experimental procedures.

Liquids having viscosities within the range of from 1 to 500 centipoise and resistivities in the range of from 102-108 ohm m can be comminuted by the present device.

As stated this method of induced charging has been found to provide better comminution of liquid having a lower electrical resistivity, such as is the case of aqueous solvents, including solvent mixtures, and solutions thereof and low resistivity organic solvents such as alcohols.

One favoured use of the device of the invention is for the dispensation of a comminuted liquid for inhalation.

Accordingly, in one preferred aspect of the invention there is provided a device for comminuting a liquid for inhalation, wherein the liquid is comminuted by an induced electrical charge.

The device of the invention may be adapted into any embodiment form which dispenses comminuted liquid for inhalation, for both medicinal and non-medicinal use.

Non-medicinal inhalation uses includes dispensing perfumes and aromas.

Preferably, the device is in the form of an inhaler, for the inhaled delivery of a medicament.

A preferred liquid is therefore a liquid medicament formulation adapted for inhaled administration.

Medicaments suitable for adaption for inhaled administration include those used for the treatment of disorders of the respiratory tract, such as reversible airways obstruction and asthma and those used in the treatment and/or prophylaxis of disorders associated with pulmonary hypertension and of disorders associated with right heart failure by inhaled delivery.

One problem associated with inhalers is coordinating the release of the liquid spray with inhalation by the user. It is a further aspect of the present invention that there is provided a means which facilitates this problem.

Accordingly, there is also provided an inhaler, comprising an electrohydrodynamic comminution means, a means for partially or fully discharging the liquid comminution and a conduit through which the liquid comminution is administered, wherein the discharging means is arranged to be activated by inhalation of the user.

Suitably, the electrohydrodynamic comminution means comprises a communition site and a charging means, the charging means acting directly or by induction to produce the required charge on the communition means, favourably acting by induction.

Suitably, the electrohydrodynamic communition means comprises a means for supplying liquid to the communition means.

One favoured arrangement wherein the discharging means is activated by inhalation of the user comprises a valve means located so as to open and close the conduit, suitably within the conduit, the valve means being opened by inhalation of the user which then activates the discharging means.

A suitable discharging means is provided by one or more capacitors or by a sharp edged or pointed electrode.

When the discharging means is a sharp edged or pointed electrode, the discharging means is preferably operationally attached to the valve means such that when the valve means opens the sharp edged or pointed electrode is thereby exposed to the communited liquid.

A suitable valve means is a flap valve.

In a particular instance the sharp edged or pointed electrode is fixed so as to extend upwards from the plane of the flap valve, the flap valve being pivotally fixed so as to open and close the conduit, such that when the flap valve pivots open the sharp edged or pointed electrode pivots into the flight path of the comminuted liquid.

Thus in a most particular instance the invention provides an inhaler, the inhaler comprising an electrohydrodynamic comminution site, a means for supplying liquid to the comminution site, a means for charging the comminution site, a sharp edged or pointed electrode for partially or fully discharging the liquid comminution and a conduit through which the liquid comminution is administered, the conduit having a valve means activated by inhalation of the user, wherein the valve means comprises a flap shaped to seal the conduit, the flap being pivotally fixed so as to open and close the conduit, the sharp edged or pointed electrode extends upwards from the plane of the flap valve, such that in use the flap valve pivots open and the discharging means pivots into the flight path of the comminuted liquid.

When the devices comprise a sharp edged or pointed electrode, the arrangement suitably provides that the sharp edged or pointed electrode is electrically shielded from the liquid comminution when the valve means is closed. One particular method of achieving this is that the sharp edged or pointed electrode pivots into a recess formed in the charging means when the valve means closes.

When used herein ‘a comminution’ includes a liquid droplet spray.

When used herein ‘medicament’ includes proprietary medicines, pharmaceutical medicines and veterinary medicines.

When used herein, unless more specifically defined herein, ‘inhaled administration’ includes administration to and via the upper respiratory tract, including the nasal mucosa, and the lower respiratory tract.

The description ‘sharp edged or pointed’ when used herein in relation to operational parts of the device, such as the electrode, also includes electrical equivalents thereof and hence includes shapes such as ridges and the like. The essential requirement is that the operational part of the device has, or a component or feature of the device has, dimensions which will give rise to a sufficiently high electrical field strength so as to exceed the breakdown strength of the air. This tropic is theoretically described in “Depositional Control of Macroscopic Particles by High Strength Electric Field Propulsion” by R A Coffee, in “Transactions of the Institution of Electrical and Electronic Engineers, Industry Applications, USA”, Vo. IA-10 pp 511 to 519, July/August 1974. An example is an electrical field strength of approximately 3 million volts per meter.

The liquid medicinal formulations for use in the device of the invention may be formulated according to conventional procedures, such as those disclosed in the U.S. Pharmacopeia, the European Pharamcopoeia, 2nd Edition, Martindale The Extra Pharmacopoeia, 29th Edition, Pharmaceutical Press and the Veterinary Pharmacopoeia.

The liquid cosmetic formulations for use in the device of the invention may be formulated according to conventional procedures, such as those disclosed in Harry's Cosmeticology, 9th Edition, 1982, George Goodwin, London.

BRIEF DESCRIPTION OF DRAWINGS

FIGS. 1 and 2 illustrate a device with a hinged flap which effects droplets ionization;

FIG. 3 shows a side view of a device which uses electrically floating conducting surfaces to effect droplet charge;

FIG. 4 shows a side view of a device with an induction ring;

FIGS. 4 a and 4 b show modifications of the device shown in FIG. 4; and

FIG. 5 illustrates a device which uses a controlled field modification technique to both discharge and recharge droplets to an optimal value.

The invention may now be described, by way of illustration, with reference to the accompanying FIGS. 1 to 5.

In FIGS. 1 and 2, a device of the invention is illustrated in which a pressure reduction created by the action of breathing through a suitable ducting (1) causes a lightweight flap (2), balanced by a second member (3) pivoted at a hinge (4) and connected to a dc high voltage supply of either polarity (5) to revolve through a sufficient degree of arc to allow the second member of the flap to become exposed to the electric field and then create gaseous ions.

The flap value thus has two actions: (a) it opens an air passage (1) to facilitate a flow of droplets; and (b) it simultaneously rotates a balancing member (3) attached to the flap (2) through a sufficient degree of arc to expose a ridge, or nipple (6) having one dimension of less than about 1.0 mm radius of curvature.

The ridge, or nipple (6) may be made of any conducting, or semi-conducting material such as metal, or carbon-loaded plastic, and is connected to a source of high voltage (5). When not actuated by breathing, the ridge will be electrically screened by the surface of a flat electrode (7), also connected to the high voltage source (5). In this position the electrode (7) may be switched on, or off by a simple switch (8).

When switched on, the electrode induces a potential of opposing polarity at the tip of a nearby nozzle (9). This induced potential causes liquid at the tip of the nozzle to emerge as a fast jet which breaks up into charged droplets. The nozzle (9) is connected to earth.

The invention therefor performs more than one function: (a) the flap valve (2) allows droplets to be inhaled only when the valve is actuated by the act of breathing; (b) the principle of induction, rather than direct nozzle charging improves the control of droplet size and maximum flow rate, for those liquids which are difficult to atomize by the electrohydrodynamic process; (c) it overcomes the inevitable consequences of induction charging, which is that the opposite polarity droplets would otherwise be so strongly attracted to the source of the induced voltage (7) that the droplets would not be available for delivery by inhalation, or other forms of deposition onto target surfaces.

In FIG. 3, one or more electrically floating conducting or semi-conducting surfaces (10), attached to one or more capacitors (11) are used to attract and capture the gaseous ions so that the electric field created by the electrode (6) acts directly upon the nozzle (8) without impingement of gas ions. Such gas ions, if allowed to reach the nozzle unimpeded would be expected to modify the electric field surrounding the nozzle so as to prevent the emerging liquid from forming the necessary jet of liquid for atomization by the electrohydrodynamic method. The capacitor(s) is chosen to have a time constant of the same order as the time required to established a spray cloud. This time constant will have a value, in seconds, which is the product of the capacitance, C and the resistance, R, of the capacitor. The value of CxR is thus chosen so that the capacitor will charge by bombardment of gaseous ions, until it reaches a sufficient potential to modify the electric field and to re-direct the ions toward the established spray cloud. Generally, the time-constant required will be of the order of seconds or a number of milliseconds. For example, a capacitor of 0.1 microfarad with a resistance of 10 megohms will produce a time constant of one second. FIG. 3 shows one configuration that will create the required induction potential at the nozzle when the electrode (7) is energized and, after a suitable period, dependent upon the position and time constant of the capacitor(s) will then re-arrange the field to allow gaseous ions to migrate into the spray cloud so as to modify the charges on all droplets to a lower (optimal) or approximately zero value. Such droplets may then be readily inhaled.

The charged droplets are prevented from impinging upon the high voltage electrode (7) by the action of fast moving gaseous ions. These ions are created by the combination of electrode voltage, say one to ten kilovolts dc, and the radius of curvature of the small dimension of the ridge or nipple (6) on the balancing member (3) and by juxtaposition of the nozzle (9), the electrode (7) and the capacitor(s) (11). The capacitor(s) (11) may be used to increase the degree of control of the shape of the field and the timing of the essential reshaping process.

Liquid is supplied to the nozzle (9) from either a container (13) by gravity feed, or by mechanical pumping, or by one of the electrokinetic pumping device. The liquid is supplied to the nozzle and the induced voltage applied by the electrode (7) before the electric field is modified to create gaseous ions by the actuation of the flap-valve (2) and/or the capacitor(s) (11). Then, at any time after the spray cloud is developed, the breath-actuated valve and/or the capacitor(s) is actuated, whereupon the droplet trajectories are modified; moving away from their direct flight to the electrode (7), through the required angle, say to flow by viscous drag in the air movement caused by normal breathing. This action is virtually instantaneous due to the extremely low inertial forces on droplets used for inhalation therapy, which are generally less than about 10.0 μm in diameter for drug inhalation.

An alternative method of creating the required induction potential to atomize the liquid and subsequently discharge the droplets before impingement upon the induction electrode is to use an induction electrode (14) such as, for example, a ring with two distinct cross-sectional radii of curvature, as shown in FIG. 4. This method may be used with or without a flap valve (2), or field modifying capacitor(s) (11). The larger radius faces toward the nozzle tip, whilst the smaller radius (say less than about 1.0 mm) faces away from the nozzle (9). It has been found that, by very careful design of the field pattern, charged droplets may have sufficient inertial force to pass through a gap in the electrode (14) without immediate impingement. Although these droplets are then almost immediately forced back to impinge upon the electrode, they may be prevented from doing so by the neutralizing action of the fast moving gaseous ions. It has been further discovered that production of gaseous ions by gas breakdown at the smaller radius of curvature may be delayed by maintaining the field strength at the electrode below the critical value until the charged droplets enter the field, whereupon they will increase the field strength to the critical value and immediately trigger the droplet discharge process.

The critical field strength and shape is a function of: electrode position, shape, and voltage; the relative positions and potentials of the nozzle and capacitor(s) surfaces and the degree and position of space charge potential created by the charged droplets.

It has also been found that the methods of controlled field modification (with time) disclosed herein may be so set as to both discharge and, if required, to recharge the droplets to an optimal value. This could be importance in, say, ensuring accurate deposition of droplets within a human lung, where both the droplet's mass, and its charge have controlling influence upon the zones of deposition within the system of airways through which the droplets pass during inhalation.

A particular example of the device and its operation is shown in FIG. 5: An earthed needle, (15) concentrically located within a non-conducting sleeve (16) allowed liquid to flow (by gravity or other light pressure) to an outlet nozzle (17) where the liquid was exposed to a strong convergent electric field provided by a high potential supplied to the flat, smooth surface of electrode (18). This resulted in an induced electrohydrodynamic (EHD) communition of the liquid emerging from capillary nozzle (17).

After the communition was established (and within less than one second) a sharp element (19) of the induction electrode (18) was exposed.

The exposure of (19) above the smooth surface of (18) produced gaseous ions of the polarity of the high voltage dc, generator (20). Since the EHD spray cloud was induced from an earthed electrode-nozzle (17), the gaseous ions and the spray droplets have opposing polarities. And as the gaseous ions have much greater mobility in the electric field containing both droplets and ions, the droplets were bombarded and hence electrically discharged.

In the experiment described, the distance between tip of nozzle (17) and flat electrode was 30 mm. When the sharp electrode (19) was positioned to discharge the droplets, the distance between tip of nozzle (17) and needle-tip (19) was 23 mm. The liquid flow-rate was 1.34 μl/sec. The high voltage source was set at a negative potential of 10.7 kilovolts.

The liquid used was 80% ethanol and 20% polyethylene glycol (200), having a viscosity of 2.2 c Poise, a surface tension of 25.0 m N/m, a resistivity of 1.7103 ohm.m and a density of 0.86 kg/liter.

The discharging effect was assessed to be essentially 100 per cent.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US27236461 Apr 195015 Nov 1955Ransburg Electro Coating CorpApparatus for electrostatic atomization and coating
US294544322 Aug 195719 Jul 1960Gen ElectricPump operation
US309676212 Feb 19629 Jul 1963Waterbury Pressed Metal CoOral breathing device
US31311313 Apr 196228 Apr 1964Socony Mobil Oil Co IncElectrostatic mixing in microbial conversions
US323229212 Oct 19621 Feb 1966Arizona Nucleonics IncIonized aerosols
US345664619 Jan 196722 Jul 1969Dart Ind IncInhalation-actuated aerosol dispensing device
US3811620 *13 Nov 197221 May 1974Mueller E Kg FaHead for powder spraying gun
US383757326 Feb 197324 Sep 1974Wagner WApparatus for electrified spraying
US389790519 Oct 19735 Aug 1975Universal Oil Prod CoElectrostatic spraying nozzle
US39300618 Apr 197430 Dec 1975Ransburg CorpElectrostatic method for forming structures and articles
US39589595 Aug 197425 May 1976Trw Inc.Method of removing particles and fluids from a gas stream by charged droplets
US40433311 Aug 197523 Aug 1977Imperial Chemical Industries LimitedFibrillar product of electrostatically spun organic material
US40444041 Aug 197530 Aug 1977Imperial Chemical Industries LimitedFibrillar lining for prosthetic device
US40730022 Nov 19767 Feb 1978Ppg Industries, Inc.Self-adjusting power supply for induction charging electrodes
US415064427 May 197724 Apr 1979Nissan Motor Company, LimitedMethod for controlling electrostatic fuel injectors
US41868864 Aug 19785 Feb 1980Ppg Industries, Inc.Adapting means providing detachable mounting of an induction-charging adapter head on a spray device
US41987813 Aug 197822 Apr 1980Lasco, Inc.Plant destruction utilizing electrically conductive liquid
US42033985 May 197720 May 1980Nissan Motor Company, LimitedElectrostatic apparatus for controlling flow rate of liquid
US4216915 *17 Apr 197812 Aug 1980Kurt BaumannElectrostatic powder spray gun
US4264641 *10 May 197828 Apr 1981Phrasor Technology Inc.Electrohydrodynamic spraying to produce ultrafine particles
US426672117 Sep 197912 May 1981Ppg Industries, Inc.Spray application of coating compositions utilizing induction and corona charging means
US435652828 Sep 197926 Oct 1982Imperial Chemical Industries PlcAtomization of liquids
US43807862 Sep 198019 Apr 1983Exxon Research And Engineering Co.Electrostatic atomizing device
US443998016 Nov 19813 Apr 1984The United States Of America As Represented By The Secretary Of The NavyElectrohydrodynamic (EHD) control of fuel injection in gas turbines
US446796111 Feb 198228 Aug 1984Imperial Chemical Industries PlcContainer and spraying system
US447651521 Oct 19829 Oct 1984Imperial Chemical Industries PlcAtomization of liquids
US45082658 Mar 19822 Apr 1985Agency Of Industrial Science & TechnologyMethod for spray combination of liquids and apparatus therefor
US45096941 Jun 19839 Apr 1985Canadian Patents & Development LimitedCross-current airfoil electrostatic nozzle
US454924313 Mar 198422 Oct 1985Imperial Chemical IndustriesSpraying apparatus
US465901214 Aug 198421 Apr 1987Imperial Chemical Industries PlcElectrostatic spraying process and apparatus
US46712699 May 19869 Jun 1987Wilp William APersonal ion inhaler device
US4702415 *18 Sep 198427 Oct 1987Vortran CorporationAerosol producing device
US470389120 Dec 19853 Nov 1987Imperial Chemical Industries PlcApparatus for spraying liquids from a moving vehicle
US473536427 Aug 19865 Apr 1988National Research Development CorporationElectrostatic spray head
US474804329 Aug 198631 May 1988Minnesota Mining And Manufacturing CompanyElectrospray coating process
US474912516 Jan 19877 Jun 1988Terronics Development Corp.Nozzle method and apparatus
US47765158 Aug 198611 Oct 1988Froughieh MichalchikElectrodynamic aerosol generator
US478801616 Jun 198729 Nov 1988Imperial Chemical Industries PlcApparatus and process for producing powders and other granular materials
US4795330 *24 Feb 19873 Jan 1989Imperial Chemical Industries PlcApparatus for particles
US480108631 May 198831 Jan 1989Imperial Chemical Industries PlcSpraying apparatus
US4811898 *21 Sep 198714 Mar 1989Nordson CorporationElectrostatic powder spray gun with adjustable deflector and electrostatic shield
US4829996 *24 Feb 198716 May 1989Imperial Chemical Industries PlcApparatus for producing a spray of droplets of a liquid
US483087220 Aug 198616 May 1989Sale Tilney Technology PlcElectrostatic coating blade and method of applying a thin layer of liquid therewith onto an object
US484640721 Apr 198711 Jul 1989Imperial Chemical Industries PlcElectrostatic spraying apparatus
US496288524 Oct 198916 Oct 1990Coffee Ronald AProcess and apparatus for spraying liquid
US497968027 Oct 198825 Dec 1990Veb Infrarot-Anlagen OranienburgSpray gun
US504456421 Nov 19893 Sep 1991Sickles James EElectrostatic spray gun
US50869721 Aug 199011 Feb 1992Hughes Aircraft CompanyEnhanced electrostatic paint deposition method and apparatus
US511597123 Sep 198826 May 1992Battelle Memorial InstituteNebulizer device
US518028817 Apr 199019 Jan 1993Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V.Microminiaturized electrostatic pump
US5196171 *11 Mar 199123 Mar 1993In-Vironmental Integrity, Inc.Electrostatic vapor/aerosol/air ion generator
US522266325 Jul 199129 Jun 1993Imperial Chemical Industries PlcElectrostatic spraying device and method using an alternating polarity high potential
US5267555 *24 Sep 19927 Dec 1993Philip PajalichApparatus and method for ionizing medication containing mists
US5341801 *30 Nov 199230 Aug 1994Sandoz Ltd.Inhaler
US538178910 Jul 199117 Jan 1995Marquardt; KlausIonizer for the ionization of oxygen in oxygen therapy
US5382410 *22 Mar 199317 Jan 1995In-Vironmental Integrity, Inc.Electrostatic vapor/aerosol generator with method and apparatus for conditioning building spaces
US5396882 *11 Mar 199214 Mar 1995The General Hospital CorporationGeneration of nitric oxide from air for medical uses
US540294522 Jan 19934 Apr 1995Gervan Company InternationalMethod for spraying plants and apparatus for its practice
US54091629 Aug 199325 Apr 1995Sickles; James E.Induction spray charging apparatus
US548395322 Jun 199516 Jan 1996The United States Of America As Represented By The Secretary Of The NavyAerosol dispensing apparatus for dispensing a medicated vapor into the lungs of a patient
US551172623 Feb 199330 Apr 1996Battelle Memorial InstituteNebulizer device
US56555171 Jun 199512 Aug 1997Electrosols, Ltd.Dispensing device
US5927618 *22 Aug 199427 Jul 1999The Procter & Gamble CompanyElectrostatic spraying device
US60796345 Dec 199727 Jun 2000The Procter & Gamble CompanyElectrostatic spraying
US6386195 *19 Aug 199914 May 2002Electrosols Ltd.Dispensing device
US6394086 *13 Nov 199828 May 2002Bespak PlcInhalation apparatus
US6457470 *20 Nov 20001 Oct 2002Electrosols Ltd.Dispensing device
DE2008769A125 Feb 19703 Sep 1970 Title not available
DE4106564A11 Mar 19913 Sep 1992Bosch Gmbh RobertElectrostatic liq. jet atomiser featuring corona discharge ring - facilitates control of spray by neutralisation of charged droplets ejected into cloud of oppositely charged ions
EP0029301A121 Oct 198027 May 1981Imperial Chemical Industries PlcElectrostatic spraying apparatus
EP0102713B112 Jul 19832 Sep 1987Imperial Chemical Industries PlcElectrostatic entrainment pump for a spraying system
EP0234842A217 Feb 19872 Sep 1987Imperial Chemical Industries PlcApparatus for producing a spray of droplets of a liquid
EP0250164A211 Jun 198723 Dec 1987Imperial Chemical Industries PlcApparatus and process for producing powders and other granular materials
EP0523962A114 Jul 199220 Jan 1993Unilever PlcCosmetic delivery system
EP0523963A114 Jul 199220 Jan 1993Unilever PlcHair and scalp treatment system
EP0523964A114 Jul 199220 Jan 1993Unilever PlcCosmetic delivery system
GB1297993A Title not available
GB1569707A Title not available
GB2018627A Title not available
GB2018627B Title not available
GB2128900A Title not available
GB2201873A Title not available
NZ191545A Title not available
NZ195704A Title not available
NZ198774A Title not available
SU1005939A1 Title not available
WO1991007232A120 Nov 199030 May 1991Sickles James EElectrostatic spray gun
WO1992015339A13 Mar 199217 Sep 1992Peltier Mark EElectrostatic vapor-aerosol generator
WO1993006937A117 Sep 199215 Apr 1993Imperial Chemical Industries PlcSpraying of liquids
Non-Patent Citations
Reference
1Article entitled: Charging Liquid Spray by Electrostatic Induction authored by: S. E. Law and H. D. Bowen: taken from Transactions of the ASAE: pp. 501-506; dated 1966.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7674429 *22 Jan 20019 Mar 2010Johnsondiversey, Inc.Electrostatic disinfectant delivery
US784985028 Feb 200314 Dec 2010Battelle Memorial InstituteNozzle for handheld pulmonary aerosol delivery device
US793102016 Nov 200626 Apr 2011Battelle Memorial InstituteDissociated discharge EHD sprayer with electric field shield
US795142831 Jan 200731 May 2011Regents Of The University Of MinnesotaElectrospray coating of objects
US79726614 Oct 20075 Jul 2011Regents Of The University Of MinnesotaElectrospraying method with conductivity control
US842451812 Jun 200923 Apr 2013Mannkind CorporationDry powder inhaler and system for drug delivery
US84851804 Mar 201016 Jul 2013Mannkind CorporationDry powder drug delivery system
US849975712 Jun 20096 Aug 2013Mannkind CorporationDry powder inhaler and system for drug delivery
US863600112 Jun 200928 Jan 2014Mannkind CorporationDry powder inhaler and system for drug delivery
US891219318 Jun 201316 Dec 2014Mannkind CorporationDry powder inhaler and system for drug delivery
US905061115 Feb 20139 Jun 2015Regents Of The University Of MinnesotaHigh mass throughput particle generation using multiple nozzle spraying
US910821731 Jan 200818 Aug 2015Nanocopoeia, Inc.Nanoparticle coating of surfaces
US919267530 Jul 201324 Nov 2015Mankind CorporationDry powder inhaler and system for drug delivery
US92206877 Nov 201429 Dec 2015Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US923315924 Oct 201212 Jan 2016Mannkind CorporationMethods and compositions for treating pain
US924190315 Jul 201326 Jan 2016Mannkind CorporationMethod for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US924821731 Jan 20072 Feb 2016Nanocopocia, LLCNanoparticle coating of surfaces
US928319310 Apr 201415 Mar 2016Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US933961514 Mar 201317 May 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US934676630 Apr 201424 May 2016Mannkind CorporationCatalysis of diketopiperazine synthesis
US935835221 Jun 20117 Jun 2016Mannkind CorporationDry powder drug delivery system and methods
US936443618 Jun 201214 Jun 2016Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
US936461919 Jun 200914 Jun 2016Mannkind CorporationInteractive apparatus and method for real-time profiling of inhalation efforts
US93933722 Jul 201319 Jul 2016Mannkind CorporationDry powder drug delivery system
US944600122 Jun 201520 Sep 2016Mannkind CorporationIncreasing drug affinity for crystalline microparticle surfaces
US944613321 Oct 201420 Sep 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US951119827 Nov 20136 Dec 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US961035113 Feb 20154 Apr 2017Mannkind CorporationMethods and compositions for treating pain
US963093011 Apr 201425 Apr 2017Mannkind CorporationDiketopiperazine microparticles with defined specific surface areas
US964269422 Dec 20149 May 2017Regents Of The University Of MinnesotaDevice with electrospray coating to deliver active ingredients
US965585018 Nov 201523 May 2017Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US96624612 May 201630 May 2017Mannkind CorporationDry powder drug delivery system and methods
US96756748 Jan 201613 Jun 2017Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
US970069012 Jun 201411 Jul 2017Mannkind CorporationInhalation apparatus
US970694424 Mar 201518 Jul 2017Mannkind CorporationApparatus and method for simulating inhalation efforts
US97176895 Feb 20161 Aug 2017Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US979668812 Apr 201624 Oct 2017Mannkind CorporationCatalysis of diketopiperazine synthesis
US98019255 Mar 201531 Oct 2017Mannkind CorporationPotentiation of glucose elimination
US980201212 Jul 201331 Oct 2017Mannkind CorporationDry powder drug delivery system and methods
US20020155026 *22 Jan 200124 Oct 2002Lins Claudio L.K.Electrostatic disinfectant delivery
US20040195403 *28 Feb 20037 Oct 2004Battelle Memorial Institute And Battellepharma, Inc.Nozzle for handheld pulmonary aerosol delivery device
US20070017505 *13 Jul 200625 Jan 2007Lipp Brian ADispensing device and method
US20070199824 *31 Jan 200730 Aug 2007Hoerr Robert AElectrospray coating of objects
US20070278103 *31 Jan 20076 Dec 2007Nanocopoeia, Inc.Nanoparticle coating of surfaces
US20080141936 *4 Oct 200719 Jun 2008Regents Of The University Of MinnesotaElectrospraying apparatus and method for coating particles
US20080308095 *16 Nov 200618 Dec 2008Ventaira Pharmaceuticals, Inc.Dissociated Discharge EHD Sprayer With Electric Field Shield
US20090308390 *12 Jun 200917 Dec 2009Smutney Chad CDry Powder Inhaler and System for Drug Delivery
US20090308392 *12 Jun 200917 Dec 2009Smutney Chad CDry Powder Inhaler and System for Drug Delivery
US20100139652 *17 Feb 201010 Jun 2010Battelle Memorial InstituteDispensing Device and Method
US20110229627 *27 May 201122 Sep 2011Nanocopoeia, Inc.Electrospray coating of objects
CN101316628B17 Jul 200614 Mar 2012巴特尔纪念研究院Improved dispensing device and method
Classifications
U.S. Classification128/200.14, 128/203.12, 128/203.27
International ClassificationA61M15/02, B05B5/00, B05B5/043, A61M15/00, B05B5/025, A61M11/00
Cooperative ClassificationA61M15/0093, B05B5/0255, B05B5/002, A61M15/02, B05B5/043, A61M15/0091
European ClassificationB05B5/00C, A61M15/00T, B05B5/025A, B05B5/043, A61M15/02
Legal Events
DateCodeEventDescription
29 Jan 2002ASAssignment
Owner name: BATTELLE MEMORIAL INSTITUTE, OHIO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELECTROSOLS LIMITED;REEL/FRAME:012520/0526
Effective date: 20011126
18 Sep 2008FPAYFee payment
Year of fee payment: 4
3 Dec 2012REMIMaintenance fee reminder mailed
19 Apr 2013LAPSLapse for failure to pay maintenance fees
11 Jun 2013FPExpired due to failure to pay maintenance fee
Effective date: 20130419